Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-10

Clinical Trial Update: Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating whether apelin improves insulin sensitivity in adults with Type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apelin (apelin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Diabetes | Phase 1 | Status: COMPLETED